Figure 1.
Patient outcomes with haploidentical donor BMT with posttransplant cyclophosphamide. (A) OS based on the TBI dose. (B) Graft-failure–free (event-free) survival.
Patient outcomes with haploidentical donor BMT with posttransplant cyclophosphamide. (A) OS based on the TBI dose. (B) Graft-failure–free (event-free) survival.
